In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
In the latest session, Bruker Corp (NASDAQ: BRKR) closed at $33.52 down -0.36% from its previous closing price of $33.64. In other words, the price has decreased by -$0.36 from its previous closing price. On the day, 1.99 million shares were traded. BRKR stock price reached its highest trading level at $34.522 during the session, while it also had its lowest trading level at $33.48.
Ratios:
For a deeper understanding of Bruker Corp’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 55.28 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 103.16. For the most recent quarter (mrq), Quick Ratio is recorded 0.70 and its Current Ratio is at 1.61. In the meantime, Its Debt-to-Equity ratio is 1.35 whereas as Long-Term Debt/Eq ratio is at 1.32.
On December 19, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $72.
On December 10, 2024, UBS started tracking the stock assigning a Neutral rating and target price of $66.UBS initiated its Neutral rating on December 10, 2024, with a $66 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 06 ’25 when LAUKIEN FRANK H bought 2,608 shares for $38.36 per share. The transaction valued at 100,043 led to the insider holds 38,462,171 shares of the business.
Bures Thomas bought 500 shares of BRKR for $23,698 on Mar 10 ’25. The Chief Accounting Officer now owns 3,472 shares after completing the transaction at $47.40 per share. On Feb 18 ’25, another insider, LAUKIEN FRANK H, who serves as the PRESIDENT & CEO of the company, bought 20,000 shares for $50.92 each. As a result, the insider paid 1,018,330 and bolstered with 38,459,563 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BRKR now has a Market Capitalization of 5085621248 and an Enterprise Value of 7527233024. As of this moment, Bruker’s Price-to-Earnings (P/E) ratio for their current fiscal year is 63.98, and their Forward P/E ratio for the next fiscal year is 14.17. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 15.45. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.48 while its Price-to-Book (P/B) ratio in mrq is 2.82. Its current Enterprise Value per Revenue stands at 2.186 whereas that against EBITDA is 13.499.
Stock Price History:
The Beta on a monthly basis for BRKR is 1.21, which has changed by -0.4849416 over the last 52 weeks, in comparison to a change of 0.15005577 over the same period for the S&P500. Over the past 52 weeks, BRKR has reached a high of $72.94, while it has fallen to a 52-week low of $30.00. The 50-Day Moving Average of the stock is -13.82%, while the 200-Day Moving Average is calculated to be -28.47%.
Shares Statistics:
For the past three months, BRKR has traded an average of 2.89M shares per day and 4084510 over the past ten days. A total of 151.72M shares are outstanding, with a floating share count of 103.07M. Insiders hold about 32.07% of the company’s shares, while institutions hold 82.87% stake in the company. Shares short for BRKR as of 1753920000 were 9327221 with a Short Ratio of 3.23, compared to 1751241600 on 9785561. Therefore, it implies a Short% of Shares Outstanding of 9327221 and a Short% of Float of 13.260000999999999.
Dividends & Splits
According to the company, the forward annual dividend rate for BRKR is 0.20, from 0.2 in the trailing year. Against a Trailing Annual Dividend Yield of 0.0059453035The stock’s 5-year Average Dividend Yield is 0.3.
Earnings Estimates
The stock of Bruker Corp (BRKR) is currently drawing attention from 11.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is $0.87, with high estimates of $0.92 and low estimates of $0.83.
Analysts are recommending an EPS of between $2.03 and $1.95 for the fiscal current year, implying an average EPS of $1.98. EPS for the following year is $2.43, with 13.0 analysts recommending between $2.83 and $2.09.
Revenue Estimates
A total of 10 analysts believe the company’s revenue will be $848.71M this quarter.It ranges from a high estimate of $859.3M to a low estimate of $838.14M. As of the current estimate, Bruker Corp’s year-ago sales were $864.4MFor the next quarter, 10 analysts are estimating revenue of $1B. There is a high estimate of $1.02B for the next quarter, whereas the lowest estimate is $972.3M.
A total of 11 analysts have provided revenue estimates for BRKR’s current fiscal year. The highest revenue estimate was $3.47B, while the lowest revenue estimate was $3.42B, resulting in an average revenue estimate of $3.45B. In the same quarter a year ago, actual revenue was $3.37BBased on 11 analysts’ estimates, the company’s revenue will be $3.51B in the next fiscal year. The high estimate is $3.58B and the low estimate is $3.45B.
